Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuebijing for severe community-acquired pneumonia
ChiCTR-TRC-13003534Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Sep 2013
- Countries
- 1
01
Overview
Phase 4, randomised trial of xuebijing in community-acquired pneumonia (CAP) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Pneumonia severity index improvement rate. Started Sep 2013; status: completed.
02
Drugs
xuebijing
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR-TRC-13003534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003534.